Brain Advance Access published online on September 23, 2003
Brain, doi:10.1093/brain/awg278
© 2003 by Guarantors of Brain
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
1 Department of Clinical Neurophysiology, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London WC1N 3JH, UK
* Corresponding author. E-mail: pittm{at}gosh.nhs.uk.
Received 27 March 2003
; revised 25 June 2003
; accepted 26 June 2003
A group of 13 patients with early onset diaphragmatic palsy in association with a progressive neuropathy is presented. All eight of those tested were found to have mutations in the same gene encoding the immunoglobulin mu-binding protein 2 (IGHMBP2) in patients with spinal muscular atrophy (SMA) with respiratory distress type 1. Six out of these eight patients had either homozygous or compound heterozygous mutations, and two had only a single heterozygous mutation. Detailed analysis of the clinical picture and the neurophysiological and histopathological findings indicated that these patients shared similar characteristics, which were further developed as a set of diagnostic criteria. Some of the most striking of these were early onset of respiratory compromise, a markedly low birth weight, very slow motor nerve conduction velocities and a general decrease in the size of myelinated fibres on sural nerve biopsy. Extensive histological examination of the spinal cord in one patient failed to find any evidence of an SMA. Four out of the five not tested genetically were positive for all diagnostic criteria. None of the cases of early onset neuropathies or spinal muscular atrophies with early respiratory failure reviewed in the literature shares the exact characteristics, but many do have very close similarities. Their classification varies, but the discovery of mutations in IGHMBP2 in cases that are variously classified as SMA plus or severe infantile neuropathy with respiratory distress points to a need for the search for this genetic defect to be widened to include both groups. The fact that we identified other, similar cases of neuropathy and early respiratory failure with and without IGHMBP2 mutations suggests genetic as well as clinical heterogeneity in these infants. It is possible that infants that do not have mutations in the IGHMBP2 gene will be found to have mutations in a similar functioning gene.
Keywords: infantile neuropathy; diaphragmatic weakness; respiratory insufficiency; respiratory paralysis; peripheral nervous system diseases
Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1
2 The National Hospital for Neurology and Neurosurgery, London, UK
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. M. Kaindl, U.-P. Guenther, S. Rudnik-Schoneborn, R. Varon, K. Zerres, M. Schuelke, C. Hubner, and K. von Au Spinal Muscular Atrophy With Respiratory Distress Type 1 (SMARD1) J Child Neurol, February 1, 2008; 23(2): 199 - 204. [Abstract] [PDF]
|
|
|
|
 |
|
 T. P. Maddatu, S. M. Garvey, D. G. Schroeder, W. Zhang, S.-Y. Kim, A. I. Nicholson, C. J. Davis, and G. A. Cox Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival Hum. Mol. Genet., November 1, 2005; 14(21): 3179 - 3189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ruiz, J. Lin, A. Forgie, D. Foletti, D. Shelton, A. Rosenthal, and L. Tabares Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice Hum. Mol. Genet., July 1, 2005; 14(13): 1825 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Grohmann, W. Rossoll, I. Kobsar, B. Holtmann, S. Jablonka, C. Wessig, G. Stoltenburg-Didinger, U. Fischer, C. Hubner, R. Martini, et al. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1) Hum. Mol. Genet., September 15, 2004; 13(18): 2031 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Maddatu, S. M. Garvey, D. G. Schroeder, T. G. Hampton, and G. A. Cox Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy Hum. Mol. Genet., June 1, 2004; 13(11): 1105 - 1115. [Abstract] [Full Text] [PDF]
|
|